Viewing Study NCT00052351


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-01-01 @ 5:32 AM
Study NCT ID: NCT00052351
Status: COMPLETED
Last Update Posted: 2013-06-19
First Post: 2003-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: CDR0000258196
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators